Bharti Bhatia | Biology | Best Researcher Award

Dr Bharti Bhatia | Biology | Best Researcher Award

Principal Scientist, Translational Health Science and Technology Institute, India

Dr. Bharti Bhatia is a Principal Scientist at the Translational Health Science and Technology Institute (THSTI) with over 10 years of expertise in vaccine development and zoonotic pathogen research. Her work focuses on developing innovative vaccine platforms using genomics, molecular biology, and immunological engineering to address emerging infectious diseases. Her recent projects include the development of Vesicular Stomatitis Virus-based vaccines for Kyasanur Forest Disease and Alkhurma Hemorrhagic Fever Virus. Dr. Bhatia is dedicated to global health security and pandemic preparedness through interdisciplinary research and collaboration. 🌍🧬

Profile

Orcid

Education

Dr. Bharti Bhatia holds a Ph.D. in Molecular Biology from the National Institute of Immunology, New Delhi (2015). She completed her Master’s in Science in Biotechnology at Jawaharlal Nehru University, New Delhi (2009), and her Bachelor’s in Science in Biotechnology, Chemistry, and Zoology from Guru Nanak Khalsa College, Kurukshetra University (2007). She further enhanced her expertise with fellowships at the Laboratory of Virology and Laboratory of Bacteriology at the National Institutes of Health (NIH), USA. 🎓🔬

Experience

Dr. Bhatia currently serves as Principal Scientist at THSTI (2024-present), where she leads the development of rapid-response vector-based vaccines against priority pathogens like Kyasanur Forest Disease Virus and Nipah. Previously, as Group Head of R&D Genomics at BBB Incubation Center, RCB Faridabad (2022-2024), she innovated the world’s first RT-PCR-based “single tube HBV detection kit.” Her earlier roles include working on the development of replication-competent vaccines against Kyasanur Forest Disease and Alkhurma Virus (2018-2021), as well as significant research on spirochete virulence in Lyme disease (2015-2018). 🔬💉

Research Interest

Dr. Bhatia’s research interests lie in vaccine discovery, vaccine platform development, and infectious disease immunology. She specializes in the development of rapid-response vaccines for viral and bacterial diseases, with a focus on zoonotic pathogens. Her work encompasses viral pathogenesis, diagnostics, and immunological approaches to combat emerging infectious diseases, ensuring global pandemic preparedness and health security. 🧬🦠

Awards

Dr. Bhatia has received several prestigious awards, including the NIH Director’s Award (2021) for her work with the Laboratory of Virology COVID-19 Research Group and the NIAID Merit Award (2020). She has been recognized with an IRTA fellowship for postdoctoral training (2015-2021) and has received multiple fellowships, including the DBT Fellowship (2009-2014) and CSIR NET Junior Research Fellowship (2008). 🏆🎖️

Publications Top Notes

Bhatia B, Tang-Huau TL, et al. “Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates,” Science Advances, 2023, PMID: 37672587.

Bharti B, Marzi A, et al. “VSV-based Kyasanur Forest Disease Virus vaccines protect mice from lethal challenge,” NPJ Vaccines, 2021, PMID: 34907224.

Bharti B*, Hillman C, et al. “Probing the role of bba30, a highly conserved gene of the Lyme disease spirochete,” Infection and Immunity, 2021, PMID: 34581605.

Bharti B, Furuyama W, et al. “Ebola Virus Glycoprotein Domains Associated with Protective Efficacy,” Vaccines, 2021, PMID: 34200548.

Solanki AK, Bhatia B, et al. “Molecular docking analysis of Clostridium perfringens beta toxin model,” Bioinformation, 2021, PMID: 35173385.

Conclusion

Dr. Bharti Bhatia’s achievements in the field of infectious diseases, vaccine development, and immunology make her an outstanding candidate for the Best Researcher Award. Her work is not only advancing scientific understanding but is also vital for improving global health security. With her groundbreaking research, she is well-positioned to lead efforts in combating emerging infectious diseases and ensuring global pandemic resilience.

Prof Dr. Girish Melkani | Molecular Biology | Excellence in Research

Prof Dr. Girish Melkani | Molecular Biology | Excellence in Research

Prof Dr. Girish Melkani, UAB, Heersink School of Medicine, United States

Dr. Girish C. Melkani is an Associate Professor of Pathology with a distinguished career focused on understanding the pathophysiological basis of human circadian/metabolic disorders linked with cardiovascular diseases, aging, and neurodegenerative diseases. His innovative work, utilizing Drosophila models, has contributed significantly to the fields of cardiometabolic disorders, sleep dysfunction, and protein misfolding diseases.

Profile 🌟

Orcid

Based on Girish C. Melkani’s biographical sketch, here’s a detailed analysis of his suitability for the “Excellence in Research” award, focusing on his strengths, areas for improvement, and a conclusion:

Strengths for the Award 💪

Circadian Rhythms and Cardiac Health: Melkani’s work on circadian rhythms and their impact on cardiac health, particularly through time-restricted feeding (TRF), represents a significant contribution to understanding age-related cardiovascular decline. His research has been published in high-impact journals like Science and Nature Communications.

Drosophila Models: The use of Drosophila models to study complex diseases such as Alzheimer’s Disease, cardiac amyloidosis, and laminopathies demonstrates his innovative approach. This model is particularly effective for studying genetic and physiological processes relevant to human health.

Protein Misfolding and Amyloid Diseases: Melkani’s research into protein misfolding and amyloid diseases, including Huntington’s Disease, provides critical insights into the mechanisms underlying these conditions and potential therapeutic targets.

Substantial Grant Support:

His research is supported by multiple NIH grants, including R01 and RF1 awards, highlighting the significant impact and continued relevance of his work. The diversity of his funding, ranging from circadian rhythms to metabolic disorders, reflects his broad expertise and the importance of his research.

Leadership and Mentorship:

Melkani’s leadership roles, including his position as co-leader of the Organismal Core at the UAB Nathan Shock Center, demonstrate his ability to guide and collaborate on high-impact research. His involvement in reviewing grants and serving on various study sections underscores his standing in the scientific community.

Recognition and Honors:

His numerous invitations to speak at prestigious conferences and workshops, such as SLEEP 2024 and the Society for Research on Biological Rhythms, attest to his influence and recognition in his field.

Areas for Improvement 🚀

Broader Dissemination of Research Findings:

While Melkani’s research is published in high-impact journals, efforts to engage with broader audiences, including non-specialist communities, could enhance the translation of his findings into public health benefits. Increased visibility in mainstream media or collaborations with public health organizations might be beneficial.

Interdisciplinary Collaboration:

Although Melkani has demonstrated effective collaboration within his field, expanding interdisciplinary partnerships with researchers in related areas such as behavioral science or clinical practice could enhance the applicability and impact of his findings.

Educational Contributions:

While his research achievements are notable, additional focus on educational contributions and outreach, such as developing new curricula or mentoring programs for students, could further strengthen his profile as a leading researcher.

Conclusion 🎯

Girish C. Melkani is highly suitable for the “Excellence in Research” award. His groundbreaking work on circadian rhythms, metabolic disorders, and protein misfolding, supported by substantial grant funding and published in leading journals, exemplifies research excellence. His leadership roles and recognition by the scientific community further underscore his impact.

Education 🎓

Dr. Melkani earned his B.Sc. in Chemistry and Biology in 1993 and his M.Sc. in Organic Chemistry in 1995 from Kumaun University, Nainital, India. He later pursued his Ph.D. in Chemistry with a focus on lipoproteins, oxidative stress, and atherosclerosis. His postdoctoral training involved studying heat shock proteins, chaperones, and contractile proteins, contributing to his expertise in cardiovascular and muscle diseases.

Experience 💼

Dr. Melkani has held several prestigious positions, including his current role as an Associate Professor at the University of Alabama Birmingham (UAB). He has also served as an Associate Professor at San Diego State University and a Visiting Scientist at renowned institutions like the Salk Institute and Sanford Burnham Prebys Medical Discovery Institute. His extensive experience spans over two decades of research and teaching in the fields of pathology and molecular biology.

Research Interests 🔬

Dr. Melkani’s research interests lie in exploring the mechanisms underlying circadian/metabolic disorders, cardiometabolic diseases, and proteinopathies. His work focuses on how genetic and lifestyle factors, such as circadian rhythms and time-restricted feeding, affect cellular and organismal physiology. His lab uses Drosophila models to study diseases like Alzheimer’s, laminopathies, and cardiovascular disorders, aiming to develop therapeutic interventions.

Awards & Honors 🏆

Dr. Melkani has received numerous awards and honors for his contributions to science, including recognition from the American Heart Association and invitations to speak at international conferences. He serves on several scientific committees and editorial boards, reflecting his leadership and influence in the field.

Publications Top notes 📚

Gill, S., Le, H., Melkani, G.C., & Panda, S. (2015). Time-restricted feeding attenuates age-related cardiac decline in Drosophila. Science. Cited by: 500+ articles. Link

Villanueva, J., Livelo, C., Trujillo, A., et al. (2019). Time-restricted feeding mitigates obesity and circadian disruption-induced skeletal muscle abnormalities. Nature Communications. Cited by: 300+ articles. Link

Melkani, G.C., Ramos, R., Bodmer, R., et al. (2013). Huntington’s disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart. PLoS Genetics. Cited by: 200+ articles. Link

Livelo, C., Guo, Y., Abou Daya, F., et al. (2023). Time-restricted feeding promotes muscle function through purine cycles and AMPK signaling in Drosophila obesity models. Nature Communications. Cited by: 150+ articles. Link